Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

No carcinogenicity study is available. Difluoromethane is not classified for mutagenicity and there is no evidence from the 13 week repeated dose toxicity study that difluoromethane is able to induce hyperplasia and/or pre-neoplastic lesions. In addition, no target organ has been identified. In conclusion, there is no indication of a carcinogenic potential for HFC-32.

Key value for chemical safety assessment

Justification for classification or non-classification

Since difluoromethane is not classified for mutagenicity and there is no evidence from the 13 week repeated dose toxicity study that difluoromethane is able to induce hyperplasia and/or pre-neoplastic lesions, the substance is currently considered non-carcinogenic. Classification according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2000 is not warranted.

Additional information

No carcinogenicity study is available. However, since difluoromethane is not classified for mutagenicity and there is no evidence from the 13 week repeated dose toxicity study that difluoromethane is able to induce hyperplasia and/or pre-neoplastic lesions there is no concern for carcinogenic properties.